Acceptability and Usability of Self-Collected Sampling for HPV Testing Among African-American Women Living in the Mississippi Delta

Women's Health Issues

Volumn 23, Issue 2, 2013, Pages

  Scarinci, Isabel C ^a   Litton, Allison G ^b   Garcés Palacio, Isabel C ^c   Partridge, Edward E ^d   Castle, Philip E ^e  

^a University of Alabama at Birmingham   (United States)

^b WALDEN UNIVERSITY   (United States)

^c UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; ATTITUDE TO ILLNESS; CANCER SCREENING; CANCER SUSCEPTIBILITY; FEASIBILITY STUDY; FEMALE; HEALTH BELIEF MODEL; HEALTH PROMOTION; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; PATIENT ATTITUDE; PRIMARY PREVENTION; SAMPLING; SECONDARY PREVENTION; SELF COLLECTED SAMPLING; UNITED STATES; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY DETECTION OF CANCER; FEASIBILITY STUDIES; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; MISSISSIPPI; PAPILLOMAVIRUS INFECTIONS; PATIENT ACCEPTANCE OF HEALTH CARE; RURAL POPULATION; SELF-EXAMINATION; SENSITIVITY AND SPECIFICITY; SOCIOECONOMIC FACTORS; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84875407972     PISSN: 10493867     EISSN: 18784321     Source Type: Journal    
DOI: 10.1016/j.whi.2012.12.003     Document Type: Article

References (56)

1. Balasubramanian A., Kulasingam S.L., Baer A., Hughes J.P., Myers E.R., Mao C., et al. Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. Journal of Lower Genital Tract Disease 2010, 14:185-195.
2. Behbakht K., Lynch A., Teal S., Degeest K., Massad S. Social and cultural barriers to Papanicolaou test screening in an urban population. Obstetrics and Gynecology 2004, 104:1355-1361.
3. Belinson J.L., Hu S., Niyazi M., Pretorius R.G., Wang H., Wen C., et al. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection. International Journal of Cancer 2010, 127:1151-1157.
4. Belinson J.L., Qiao Y.L., Pretorius R.G., Zhang W.H., Rong S.D., Huang M.N., et al. Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. International Journal of Gynecological Cancer 2003, 13:819-826.
5. Borelli B. Smoking cessation: next steps for special populations research and innovative treatments. Journal of Consulting and Clinical Psychology 2010, 78:1-12.
6. Brewster W.R., Hubbell F.A., Largent J., Ziogas A., Lin F., Howe S., et al. Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial. Journal of the American Medical Association 2005, 294:2182-2187.
7. Burnett C.B., Steakley C.S., Tefft M.C. Barriers to breast and cervical cancer screening in underserved women of the District of Columbia. Oncology Nursing Forum 1995, 22:1551-1557.
8. Castle P.E., Aftab A., Saint-Jean G., Mendez L. Detection of carcinogenic human papillomavirus in specimens collected with a novel self-sampling device. Journal of Clinical Microbiology 2006, 44:2158-2159.
9. Castle P.E., Glass A.G., Rush B.B., Scott D.R., Wentzensen N., Gage J.C., et al. Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up. Journal of Clinical Oncology 2012, 30:3044-3050.
10. Castle P.E., Rausa A., Walls T., Gravitt P.E., Partridge E.E., Olivo V., et al. Comparative community outreach to increase cervical cancer screening in the Mississippi Delta. Preventive Medicine 2011, 52:452-455.
11. Castle P.E., Sadorra M., Garcia F.A., Cullen A.P., Lorincz A.T., Mitchell A.L., et al. Mouthwash as a low-cost and safe specimen transport medium for human papillomavirus DNA testing of cervicovaginal specimens. Cancer Epidemiology, Biomarkers, and Prevention 2007, 16:840-843.
12. Castle P.E., Stoler M.H., Wright T.C., Sharma A., Wright T.L., Behrens C.M. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncology 2011, 12:880-890.
13. Cates J.R., Brewer N.T., Fazekas K.I., Mitchell C.E., Smith J.S. Racial differences in HPV knowledge, HPV vaccine acceptability, and related beliefs among rural, southern women. Journal of Rural Health 2009, 25:93-97.
14. Centers for Disease Control and Prevention. (N.D.) Alabama National Breast and Cervical Early Detection Program. Available from: http://www.cdc.gov/cancer/nbccedp/data/summaries/alabama.
15. Cervix cancer screening. IARC handbooks of cancer prevention 2005, IARC Press, Lyon, France.
16. Chernesky M.A., Hook E.W., Martin D.H., Lane J., Johnson R., Jordan J.A., et al. Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections. Sexually Transmitted Disease 2005, 32:729-733.
17. Cuzick J., Clavel C., Petry K.U., Meijer C.J., Hoyer H., Ratnam S., et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. International Journal of Cancer 2006, 119:1095-1101.
18. De Alba I., Anton-Culver H., Hubbell F.A., Ziogas A., Hess J.R., Bracho A., et al. Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women. Cancer Epidemiology, Biomarkers & Prevention 2008, 17:2163-2168.
19. Dillner J., Rebolj M., Birembaut P., Petry K.U., Szarewski A., Munk C., et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. British Medical Journal 2008, 337:a1754.
20. D'Urso J., Thompson-Robinson M., Chandler S. HPV knowledge and behaviors of black college students at a historically black university. Journal of American College Health 2007, 56:159-163.
21. Edwards B.K., Ward E., Kohler B.A., Eheman C., Zauber A.G., Anderson R.N., et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010, 116:544-573.
22. Fouad M.N., Nagy M.C., Johnson R.E., Wynn T.A., Patridge E.E., Dignan M. The development of a community action plan to reduce breast and cervical cancer disparities between African-American and white women. Ethnicity & Disease 2004, 14:S53-S60.
23. Freeman H.P., Wingrove B.K. Excess cervical cancer mortality: a marker for low access to health care in poor communities 2007, NIH Pub. No. 05-5282, National Institutes of Health, Bethesda, MD.
24. Gage J.C., Partridge E.E., Rausa A., Gravitt P.E., Wacholder S., Schiffman M., et al. Comparative performance of human papillomavirus DNA testing using novel sample collection methods. Journal of Clinical Microbiology 2011, 49:4185-4189.
25. Garcia F., Barker B., Santos C., Brown E.M., Nuño T., Giuliano A., et al. Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus. Obstetrics and Gynecology 2003, 102:266-272.
26. Gravitt P.E., Lacey J.V., Brinton L.A., Barnes W.A., Kornegay J.R., Greenberg M.D., et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiology, Biomarkers and Prevention 2001, 10:95-100.
27. Harper D.M., Hildesheim A., Cobb J.L., Greenberg M., Vaught J., Lorincz A.T. Collection devices for human papillomavirus. Journal of Family Practice 1999, 48:531-535.
28. Harper D.M., Longacre M.R., Noll W.M., Belloni D.R., Cole B.F. Factors affecting the detection rate of human papillomavirus. Annals of Family Medicine 2003, 1:221-227.
29. Harper D.M., Noll W.W., Belloni D.R., Cole B.F. Randomized clinical trial of PCR-determined human papillomavirus detection methods: Self-sampling versus clinician-directed-biologic concordance and women's preferences. American Journal of Obstetrics and Gynecology 2002, 186:365-373.
30. Hoyo C., Yarnall K.S., Skinner C.S., Moorman P.G., Sellers D., Reid L. Pain predicts non-adherence to Pap smear screening among middle-aged African American women. Preventive Medicine 2005, 41:439-445.
31. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA: Cancer Journal for Clinicians 2010, 60:277-300.
32. Jennings K.M. Getting a Pap smear: Focus group responses of African American and Latina women. Oncology Nursing Forum 1997, 24:827-835.
33. Jennings-Dozier K. Predicting intentions to obtain a Pap smear among African American and Latina women: testing the theory of planned behavior. Nursing Research 1999, 48:198-205.
34. Kahn J.A., Slap G.B., Huang B., Rosenthal S.L., Wanchick A.M., Kollar L.M., et al. Comparison of adolescent and young adult self-collected and clinician-collected samples for human papillomavirus. Obstetrics and Gynecology 2004, 105:952-959.
35. Lenselink C.H., de Bie R.P., van Hamont D., Bakkers J.M., Quint W.G., Massuger L.F., et al. Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: New possibilities for cervical cancer screening. Journal of Clinical Microbiology 2009, 47:2564-2570.
36. Lindau S.T., Hoffmann J.N., Lundeen K., Jaszczak A., McClintock M.K., Jordan J.A. Vaginal self-swab specimen collection in a home-based survey of older women: Methods and applications. Journals of Gerontology: Series B, Psychological Sciences and Social Sciences 2009, 64(1):i106-i118.
37. Lisovicz N., Johnson R.E., Higginbotham J., Downey J.A., Hardy C.M., Fouad M.N., et al. The Deep South Network for cancer control. Building a community infrastructure to reduce cancer health disparities. Cancer 2006, 107:1971-1979.
38. Lisovicz N., Wynn T., Fouad M., Partridge E.E. Cancer health disparities: what we have done. American Journal of Medical Sciences 2008, 335:254-259.
39. Mayrand M.H., Duarte-Franco E., Rodrigues I., Walter S.D., Hanley J., Ferenczy A., et al. Canadian Cervical Cancer Screening Trial Study Group. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. New England Journal of Medicine 2007, 357:1579-1588.
40. Mississippi Cancer Registry. Cervical cancer incidence and mortality, 2003-2007. Available from: http://www.cancer-rates.info.
41. Morrison E.A.B., Goldberg G.L., Hagan R.J., Kadish A.S., Burk R.D. Self-administered home cervicovaginal lavage: A novel tool for the clinical- epidemiologic investigation of genital human papillomavirus infections. American Journal of Obstetrics and Gynecology 1992, 167:104-107.
42. Moscicki A.B. Comparison between methods for human papillomavirus DNA testing: a model for self-testing in young women. Journal of Infectious Diseases 1993, 167:723-725.
43. Naucler P., Ryd W., Törnberg S., Strand A., Wadell G., Elfgren K., et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. New England Journal of Medicine 2007, 357:1589-1597.
44. Ogilvie G., Krajden M., Maginley J., Isaac-Renton J., Hislop G., Elwood-Martin R., et al. Feasibility of self-collection of specimens for human papillomavirus testing in hard to reach women. Canadian Medical Association Journal 2007, 177:480-483.
45. Palmisano M.E., Gaffga A.M., Daigle J., Brinkman J., Mire K., Lenczyk K., et al. Detection of human papillomavirus DNA in self-administered vaginal swabs as compared to cervical swabs. International Journal of STD & AIDS 2003, 14:560-567.
46. Partridge E., Fouad M. Community-driven approaches for reducing health disparities in cancer. Journal of the American Medical Association 2010, 303:1090-1091.
47. Rijkaart D.C., Berkhof J., Rozendaal L., van Kemenade F.J., Bulkmans N.W., Heideman D.A., et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: Final results of the POBASCAM randomised controlled trial. Lancet Oncology 2012, 13:78-88.
48. Rompalo A.M., Gaydos C.A., Shah N., Tennant M., Crotchfelt K.A., Madico G., et al. Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women. Clinical Infectious Diseases 2001, 33:1455-1461.
49. Ronco G., Giorgi-Rossi P., Carozzi F., Confortini M., Dalla Palma P., Del Mistro A., et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: A randomised controlled trial. Lancet Oncology 2010, 11:249-257.
50. Rosenstock I.M. The Health Belief Model: explaining health behavior through expectancies. Health behavior and health education: Theory, research, and practice 1990, 39-61. Jossey-Bass, San Francisco. K. Glanz, F.M. Lewis, B.K. Rimer (Eds.).
51. Sankaranarayanan R., Nene B.M., Shastri S.S., Jayant K., Muwonge R., Budukh A.M., et al. HPV screening for cervical cancer in rural India. New England Journal of Medicine 2009, 360:1385-1394.
52. Scarinci I.C., Garcia F.A., Kobetz E., Partridge E.E., Brandt H.M., Bell M.C., et al. Cervical cancer prevention: new tools and old barriers. Cancer 2010, 116:2531-2542.
53. Scarinci I.C., Johnson R.E., Hardy C., Marron J., Partridge E.E. Planning and implementation of a participatory evaluation strategy: A viable approach in the evaluation of community-based participatory programs addressing cancer disparities. Program Planning and Evaluation 2009, 32:221-228.
54. Submaniam A., Fauci J.M., Schneider K.E., Whitworth J.M., Erickson B.K., et al. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?. Journal of Lower Genital Tract Disease 2011, 15:110-113.
55. U.S. Census. Factfinder Mississippi. Available from: http://factfinder.census.gov/home.
56. Zhao F.H., Lewkowitz A.K., Chen F., Lin M.J., Hu S.Y., Zhang X., et al. Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method. Journal of the National Cancer Institute 2012, 104:178-188.